When Should You Reduce Blood Pressure Meds? (TRT Q&As)
Timeline
Bill asks how to know when weight loss and lower blood pressure justify reducing medications such as Bystolic. Dr. O’Connor says medication changes should ideally be coordinated with a clinician and guided by consistent home blood pressure readings, symptoms, and a defined blood pressure goal rather than weight loss alone.
John explains that he stopped metformin and Jardiance after losing weight and improving his glucose and A1C. Dr. O’Connor praises the lifestyle changes but says an A1C around 6.0 is still in the prediabetic range and that some medication, particularly metformin, may still provide useful metabolic and cardiovascular protection.
John questions why he was prescribed atorvastatin when his cholesterol and LDL looked good. Dr. O’Connor explains that the decision should not be based only on a current LDL value and recommends assessing actual cardiovascular risk, including coronary artery calcium, before deciding how aggressively cholesterol should be treated.
Vic asks about colchicine after hearing about its cardiovascular use. Dr. O’Connor explains that colchicine is an old gout medication that has also been studied for residual vascular inflammation, but it does not replace the cholesterol-lowering role of a statin and is used for a different cardiovascular purpose.
Vic reports an hs-CRP of 0.4 while discussing whether colchicine could help reduce cardiovascular inflammation. Dr. O’Connor says a level that low does not suggest significant residual inflammation, so he does not see a reason to add colchicine simply for that purpose at this time.
John asks which medication Dr. O’Connor would favor now that his weight and glucose have improved. Dr. O’Connor favors metformin in his situation and says Jardiance is generally more compelling when additional issues such as significant diabetes, heart failure, cardiovascular disease, or kidney disease are present.
Video Summary
Participants raise questions about it's it's and related changes while discussing testosterone therapy. The clinician frames the issue in terms of patterns and context rather than one-off impressions. Examples in the conversation clarify what details make a report more interpretable. The opening portion emphasizes what listeners should notice when describing symptoms.
Attention shifts toward practical factors such as heart disease and how day-to-day consistency affects interpretation. The clinician explains how timing and communication can change how progress is understood. When participants ask clarifying questions, the answers stay tied to what was actually described. The middle portion reinforces careful observation without drifting into generic advice.
Later questions bring in calcium score and other monitoring topics that arise during follow-up conversations. Discussion of lose weight focuses on interpretation and what makes a result clinically meaningful. The conversation returns to have heart as participants refine what they are experiencing. It closes by outlining what information about have have is most useful to share before the next visit.
Drug Callouts
Condition Callouts
Key Takeaways
- it's it's is easier to interpret when it is described consistently across time.
- The session links heart disease reports to follow-up decisions without relying on assumptions.
- Questions about calcium score are handled through context, not isolated impressions.
- Monitoring conversations emphasize what makes lose weight clinically meaningful.
- Clear reporting around have heart improves the usefulness of follow-up discussions.